Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease

English version České info

The ability for a host to recognize infection is critical for virus clearance and often begins with induction of inflammation. The PB1-F2 of pathogenic influenza A viruses (IAV) contributes to the pathophysiology of infection, although the mechanism for this is unclear. The NLRP3-inflammasome has been implicated in IAV pathogenesis, but whether IAV virulence proteins can be activators of the complex is unknown. We investigated whether PB1-F2-mediated activation of the NLRP3-inflammasome is a mechanism contributing to overt inflammatory responses to IAV infection. We show PB1-F2 induces secretion of pyrogenic cytokine IL-1β by activating the NLRP3-inflammasome, contributing to inflammation triggered by pathogenic IAV. Compared to infection with wild-type virus, mice infected with reverse engineered PB1-F2-deficient IAV resulted in decreased IL-1β secretion and cellular recruitment to the airways. Moreover, mice exposed to PB1-F2 peptide derived from pathogenic IAV had enhanced IL-1β secretion compared to mice exposed to peptide derived from seasonal IAV. Implicating the NLRP3-inflammasome complex specifically, we show PB1-F2 derived from pathogenic IAV induced IL-1β secretion was Caspase-1-dependent in human PBMCs and NLRP3-dependent in mice. Importantly, we demonstrate PB1-F2 is incorporated into the phagolysosomal compartment, and upon acidification, induces ASC speck formation. We also show that high molecular weight aggregated PB1-F2, rather than soluble PB1-F2, induces IL-1β secretion. Furthermore, NLRP3-deficient mice exposed to PB1-F2 peptide or infected with PB1-F2 expressing IAV were unable to efficiently induce the robust inflammatory response as observed in wild-type mice. In addition to viral pore forming toxins, ion channel proteins and RNA, we demonstrate inducers of NLRP3-inflammasome activation may include disordered viral proteins, as exemplified by PB1-F2, acting as host pathogen ‘danger’ signals. Elucidating immunostimulatory PB1-F2 mediation of NLRP3-inflammasome activation is a major step forward in our understanding of the aetiology of disease attributable to exuberant inflammatory responses to IAV infection.

Vyšlo v časopise: Activation of the NLRP3 Inflammasome by IAV Virulence Protein PB1-F2 Contributes to Severe Pathophysiology and Disease. PLoS Pathog 9(5): e32767. doi:10.1371/journal.ppat.1003392
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003392

Souhrn

Zdroje

1. PangIK, IwasakiA (2011) Inflammasomes as mediators of immunity against influenza virus. Trends in immunology 32: 34–41.

2. AllenIC, ScullMA, MooreCB, HollEK, McElvania-TeKippeE, et al. (2009) The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30: 556–565.

3. BrozP, MonackDM (2011) Molecular mechanisms of inflammasome activation during microbial infections. Immunological reviews 243: 174–190.

4. OwenDM, GaleMJr (2009) Fighting the flu with inflammasome signaling. Immunity 30: 476–478.

5. MartinonF, MayorA, TschoppJ (2009) The inflammasomes: guardians of the body. Annual review of immunology 27: 229–265.

6. HornungV, BauernfeindF, HalleA, SamstadEO, KonoH, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature immunology 9: 847–856.

7. HalleA, HornungV, PetzoldGC, StewartCR, MonksBG, et al. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nature immunology 9: 857–865.

8. IchinoheT, LeeHK, OguraY, FlavellR, IwasakiA (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. The Journal of experimental medicine 206: 79–87.

9. ThomasPG, DashP, AldridgeJRJr, EllebedyAH, ReynoldsC, et al. (2009) The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30: 566–575.

10. IchinoheT, PangIK, IwasakiA (2010) Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nature immunology 11: 404–410.

11. IchinoheT, PangIK, KumamotoY, PeaperDR, HoJH, et al. (2011) Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proceedings of the National Academy of Sciences of the United States of America 108: 5354–5359.

12. McAuleyJL, HornungF, BoydKL, SmithAM, McKeonR, et al. (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell host & microbe 2: 240–249.

13. ZamarinD, OrtigozaMB, PaleseP (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. Journal of virology 80: 7976–7983.

14. McAuleyJL, ChipukJE, BoydKL, Van De VeldeN, GreenDR, et al. (2010) PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS pathogens 6: e1001014.

15. PerroneLA, PlowdenJK, Garcia-SastreA, KatzJM, TumpeyTM (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4: e1000115.

16. SolbakSM, SharmaA, BrunsK, RoderR, MitznerD, et al. (2012) Influenza A virus protein PB1-F2 from different strains shows distinct structural signatures. Biochimica et biophysica acta 1834 ((2)) 568–582.

17. MastersSL, DunneA, SubramanianSL, HullRL, TannahillGM, et al. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nature immunology 11: 897–904.

18. ChevalierC, Al BazzalA, VidicJ, FevrierV, BourdieuC, et al. (2010) PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments. J Biol Chem 285: 13233–13243.

19. KedzierskaK, La GrutaNL, TurnerSJ, DohertyPC (2006) Establishment and recall of CD8+ T-cell memory in a model of localized transient infection. Immunological reviews 211: 133–145.

20. McAuleyJL, ChipukJE, BoydKL, Van De VeldeN, GreenDR, et al. (2010) PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 6: e1001014.

21. McAuleyJL, HornungF, BoydKL, SmithAM, McKeonR, et al. (2007) Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2: 240–249.

22. MastersSL, O'NeillLA (2011) Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. Trends in molecular medicine 17: 276–282.

23. HanJ, BurgessK (2010) Fluorescent indicators for intracellular pH. Chemical reviews 110: 2709–2728.

24. Fernandes-AlnemriT, WuJ, YuJW, DattaP, MillerB, et al. (2007) The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell death and differentiation 14: 1590–1604.

25. MariathasanS, WeissDS, NewtonK, McBrideJ, O'RourkeK, et al. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228–232.

26. MasonKM, MunsonRSJr, BakaletzLO (2005) A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect Immun 73: 599–608.

27. SchroderK, TschoppJ (2010) The inflammasomes. Cell 140: 821–832.

28. TisoncikJR, KorthMJ, SimmonsCP, FarrarJ, MartinTR, et al. (2012) Into the eye of the cytokine storm. Microbiology and molecular biology reviews : MMBR 76: 16–32.

29. MartinonF, PetrilliV, MayorA, TardivelA, TschoppJ (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237–241.

30. DudekSE, WixlerL, NordhoffC, NordmannA, AnhlanD, et al. (2011) The influenza virus PB1-F2 protein has interferon antagonistic activity. Biological chemistry 392: 1135–1144.

31. ConenelloGM, TisoncikJR, RosenzweigE, VargaZT, PaleseP, et al. (2011) A Single N66S Mutation in the PB1-F2 Protein of Influenza A Virus Increases Virulence by Inhibiting the Early Interferon Response In Vivo. J Virol 85: 652–662.

32. VargaZT, RamosI, HaiR, SchmolkeM, Garcia-SastreA, et al. (2011) The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS pathogens 7: e1002067.

33. ChevalierC, Al BazzalA, VidicJ, FevrierV, BourdieuC, et al. (2010) PB1-F2 influenza A virus protein adopts a beta-sheet conformation and forms amyloid fibers in membrane environments. The Journal of biological chemistry 285: 13233–13243.

34. CloonanSM, ChoiAM (2012) Mitochondria: commanders of innate immunity and disease? Current opinion in immunology 24: 32–40.

35. VargaZT, PaleseP (2011) The influenza A virus protein PB1-F2: killing two birds with one stone? Virulence 2: 542–546.

36. XueB, WilliamsRW, OldfieldCJ, GohGK, DunkerAK, et al. (2010) Viral disorder or disordered viruses: do viral proteins possess unique features? Protein and peptide letters 17: 932–951.

37. ConenelloGM, TisoncikJR, RosenzweigE, VargaZT, PaleseP, et al. (2011) A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. Journal of virology 85: 652–662.

38. AlymovaIV, GreenAM, van de VeldeN, McAuleyJL, BoydKL, et al. (2011) Immunopathogenic and Antibacterial Effects of H3N2 Influenza A Virus PB1-F2 Map to Amino Acid Residues 62, 75, 79, and 82. Journal of virology 85: 12324–12333.

39. PenaL, VincentAL, LovingCL, HenningsonJN, LagerKM, et al. (2012) Restored PB1-F2 in the 2009 Pandemic H1N1 Influenza Virus Has Minimal Effects in Swine. Journal of virology 86: 5523–5532.

40. HornungV, AblasserA, Charrel-DennisM, BauernfeindF, HorvathG, et al. (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514–518.

41. WiseHM, FoegleinA, SunJ, DaltonRM, PatelS, et al. (2009) A complicated message: identification of a novel PB1-related protein translated from influenza A segment 2 mRNA. J Virol 81: 8021–8031.

42. TauberS, LigertwoodY, Quigg-NicolM, DutiaBM, ElliottRM (2012) Behaviour of influenza A viruses differentially expressing segment 2 gene products in vitro and in vivo. The Journal of general virology 93: 840–849.

43. ZamarinD, OrtigozaMB, PaleseP (2006) Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80: 7976–7983.

44. PenaL, VincentAL, LovingCL, HenningsonJN, LagerKM, et al. (2012) Strain-dependent effects of PB1-F2 of triple-reassortant H3N2 influenza viruses in swine. The Journal of general virology 93: 2204–2214.

45. LiuB, MoriI, HossainMJ, DongL, TakedaK, et al. (2004) Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. The Journal of general virology 85: 423–428.

46. DentonAE, DohertyPC, TurnerSJ, La GrutaNL (2007) IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells. European journal of immunology 37: 368–375.

47. SmithDE (2011) The biological paths of IL-1 family members IL-18 and IL-33. Journal of leukocyte biology 89: 383–392.

48. GuardaG, BraunM, StaehliF, TardivelA, MattmannC, et al. (2011) Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 34: 213–223.

49. HoffmannE, KraussS, PerezD, WebbyR, WebsterRG (2002) Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20: 3165–3170.

50. McAuleyJL, ZhangK, McCullersJA (2010) The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. Journal of virology 84: 558–564.